These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30392561)

  • 1. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems.
    Pasquer QTL; Tsakoumagkos IA; Hoogendoorn S
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoaffinity labelling strategies for mapping the small molecule-protein interactome.
    Burton NR; Kim P; Backus KM
    Org Biomol Chem; 2021 Sep; 19(36):7792-7809. PubMed ID: 34549230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoproteomics, A Broad Avenue to Target Deconvolution.
    Gao Y; Ma M; Li W; Lei X
    Adv Sci (Weinh); 2024 Feb; 11(8):e2305608. PubMed ID: 38095542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoaffinity labeling in target- and binding-site identification.
    Smith E; Collins I
    Future Med Chem; 2015; 7(2):159-83. PubMed ID: 25686004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advances in protein precipitation-based methods for drug-target screening].
    Liu T; Qin WJ; Yang HJ
    Se Pu; 2024 Jul; 42(7):613-622. PubMed ID: 38966970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions.
    Ji H; Lu X; Zhao S; Wang Q; Liao B; Bauer LG; Huber KVM; Luo R; Tian R; Tan CSH
    Cell Chem Biol; 2023 Nov; 30(11):1478-1487.e7. PubMed ID: 37652024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity-Based Protein Profiling (ABPP) of Oxidoreductases.
    Fuerst R; Breinbauer R
    Chembiochem; 2021 Feb; 22(4):630-638. PubMed ID: 32881211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An electroaffinity labelling platform for chemoproteomic-based target identification.
    Kawamata Y; Ryu KA; Hermann GN; Sandahl A; Vantourout JC; Olow AK; Adams LA; Rivera-Chao E; Roberts LR; Gnaim S; Nassir M; Oslund RC; Fadeyi OO; Baran PS
    Nat Chem; 2023 Sep; 15(9):1267-1275. PubMed ID: 37322100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target identification and mechanism of action in chemical biology and drug discovery.
    Schenone M; Dančík V; Wagner BK; Clemons PA
    Nat Chem Biol; 2013 Apr; 9(4):232-40. PubMed ID: 23508189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Cellular Thermal Shift Assays in Research and Drug Discovery.
    Henderson MJ; Holbert MA; Simeonov A; Kallal LA
    SLAS Discov; 2020 Feb; 25(2):137-147. PubMed ID: 31566060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability-based approaches in chemoproteomics.
    George AL; Dueñas ME; Marín-Rubio JL; Trost M
    Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced mapping of small-molecule binding sites in cells.
    Wozniak JM; Li W; Governa P; Chen LY; Jadhav A; Dongre A; Forli S; Parker CG
    Nat Chem Biol; 2024 Jul; 20(7):823-834. PubMed ID: 38167919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping Protein Targets of Bioactive Small Molecules Using Lipid-Based Chemical Proteomics.
    Lum KM; Sato Y; Beyer BA; Plaisted WC; Anglin JL; Lairson LL; Cravatt BF
    ACS Chem Biol; 2017 Oct; 12(10):2671-2681. PubMed ID: 28930429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes.
    Dominguez E; Galmozzi A; Chang JW; Hsu KL; Pawlak J; Li W; Godio C; Thomas J; Partida D; Niessen S; O'Brien PE; Russell AP; Watt MJ; Nomura DK; Cravatt BF; Saez E
    Nat Chem Biol; 2014 Feb; 10(2):113-21. PubMed ID: 24362705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in silico Approach for Integrating Phenotypic and Target-based Approaches in Drug Discovery.
    Iwata H; Kojima R; Okuno Y
    Mol Inform; 2020 Jan; 39(1-2):e1900096. PubMed ID: 31638744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Medication Development: New Targets and New Drugs.
    Kasten CR; Boehm SL
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1418-24. PubMed ID: 27177689
    [No Abstract]   [Full Text] [Related]  

  • 18. A Versatile Isocyanate-Mediated Strategy for Appending Chemical Tags onto Drug-Like Small Molecules.
    Henry CC; Kruell JA; Wilson RM; Chang CF; Woo CM; Koehler AN
    Bioconjug Chem; 2023 Dec; 34(12):2181-2186. PubMed ID: 38052453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labelled chemical probes for demonstrating direct target engagement in living systems.
    Prevet H; Collins I
    Future Med Chem; 2019 May; 11(10):1195-1224. PubMed ID: 31280668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification.
    Chen X; Wang Y; Ma N; Tian J; Shao Y; Zhu B; Wong YK; Liang Z; Zou C; Wang J
    Signal Transduct Target Ther; 2020 May; 5(1):72. PubMed ID: 32435053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.